The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins
Abstract
The Rho family of small GTPases are critical elements involved in the regulation of signal transduction cascades from extracellular stimuli to the cell nucleus, including the JNK/SAPK signaling pathway, the c-fos serum response factor, and the p70 S6 kinase. Here we report a novel signaling pathway activated by the Rho proteins that may be responsible for their biological activities, including cytoskeleton organization, transformation, apoptosis, and metastasis. The human RhoA, CDC42, and Rac-1 proteins efficiently induce the transcriptional activity of nuclear factor kappaB (NF-kappaB) by a mechanism that involves phosphorylation of Ikappa Balpha and translocation of p50/p50 and p50/p65 dimers to the nucleus, but independent of the Ras GTPase and the Raf-1 kinase. We also show that activation of NF-kappaB by TNFalpha depends on CDC42 and RhoA, but not Rac-1 proteins, because this activity is drastically inhibited by their respective dominant-negative mutants. In contrast, activation of NF-kappaB by UV light was not affected by Rho, CDC42, or Rac-1 dominant-negative mutants. Thus, members of the Rho family of GTPases are involved specifically in the regulation of NF-kappaB-dependent transcription.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and is therefore associated with phagocyte immunodeficiency in humans17,18,19,20,21,22,23.”
From Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders (2013) · cites this paper as [18]
In the citing paper
“Rac2 has been identified as a component of the phagocytic oxidase complex in neutrophils (Figure 1A)”
From Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders (2013) · cites this paper as [18]
In the citing paper
“its deficiency results in impairment of both neutrophil chemotaxis in response to Formylmethionyl-Leucyl-Phenylalanine (fMLP) and superoxide production”
From Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders (2013) · cites this paper as [18]
In the citing paper
“RhoA, Rac1, and CDC42 activate the nuclear transcription factor 𝛋 B (NF𝛋 B) (46)”
From The Hematopoiesis-Specific GTP-Binding Protein RhoH Is GTPase Deficient and Modulates Activities of Other Rho GTPases by an Inhibitory Function (2002) · cites this paper as [46]
In the citing paper
“existing evidence suggests that these GTPases do so by inducing or enhancing the phosphorylation of I 𝛋 B (46).”
From The Hematopoiesis-Specific GTP-Binding Protein RhoH Is GTPase Deficient and Modulates Activities of Other Rho GTPases by an Inhibitory Function (2002) · cites this paper as [46]
Citations
Cites
The GTPase superfamily: conserved structure and molecular mechanism
Bourne, H. R., Sanders, D. A., & McCormick, F. (1991) · Nature · doi:10.1038/349117a0 · Cited by 3,392
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
Research works printed but not linked: 76
- 10.1126/science.271.5249.648 · DOI
- 1991, Induction of NF-κB DNA-binding activity during the G0-to-G1 transtition in mouse fibroblasts., Mol. Cell. Biol., 11, 4943
- 1994, Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation., Oncogene, 9, 3189
- 10.1016/0968-0004(94)90147-3 · DOI
- 10.1038/366643a0 · DOI
- 10.1038/348125a0 · DOI
- 1993, Neutro-phil phospholipase D is activated by a membrane-associated Rho family small molecular weight GTP-binding protein., J. Biol. Chem., 268, 21509, 10.1016/S0021-9258(20)80570-5 · DOI
- 1995, Coupling of signal response domain in IκBα to multiple pathways for NFκB activation., Mol. Cell. Biol., 15, 2809, 10.1128/MCB.15.5.2809 · DOI
- 10.1126/science.7878466 · DOI · Paper page
- 10.1101/gad.6.4.545 · DOI
- 10.1016/S0092-8674(00)81064-8 · DOI
- 10.1016/0092-8674(95)90071-3 · DOI · Paper page
- 10.1016/0092-8674(94)90259-3 · DOI
- 10.1016/S0092-8674(00)81257-X · DOI · Paper page
- 10.1038/365403a0 · DOI
- 10.1016/0092-8674(95)90068-3 · DOI
- 10.1016/S0092-8674(05)80018-2 · DOI · Paper page
- 10.1016/0092-8674(94)90380-8 · DOI · Paper page
- 10.1126/science.8367725 · DOI
- 1995, Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis., Oncogene, 11, 2657
- 1995, A novel human protease similar to the interleukin-1B converting enzyme induces apoptosis in transfected cells., EMBO J., 9, 1914
- 1988, Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity to GDP., Mol. Cell. Biol., 8, 3235
- 10.1074/jbc.270.42.25172 · DOI
- 10.1074/jbc.270.17.9833 · DOI
- 1982, Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells., Mol. Cell. Biol., 2, 1044
- 10.1042/bj2900297 · DOI
- 10.1084/jem.180.2.525 · DOI
- 10.1146/annurev.cb.10.110194.000335 · DOI
- 10.1016/S0092-8674(05)80020-0 · DOI
- 10.1074/jbc.271.22.13234 · DOI
- 10.1016/0092-8674(95)90070-5 · DOI
- 10.1016/S1074-7613(00)80252-6 · DOI · Paper page
- 1996, The small GTP-binding protein Rho-Binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase., EMBO J., 15, 1885, 10.1002/j.1460-2075.1996.tb00539.x · DOI
- 1991, The ras-related gene rho B is an immediate early gene inducible by v-fps, epidermal growth factor and plateled-derived growth factor in rat fibroblasts., Mol. Cell. Biol., 11, 3682
- 10.1073/pnas.91.1.73 · DOI
- 1995, Induction of apoptosis in NIH3T3 cells after serum deprivation by over-expression of rho-p21, a GTPase protein of the ras superfamily., Oncogene, 10, 811
- 10.1016/0955-0674(94)90035-3 · DOI
- 1995, Activation of Rac 1, Rho A, and mitogen-activated protein kinases is required for Ras transformation., Mol. Cell. Biol., 15, 6443, 10.1128/MCB.15.11.6443 · DOI · Paper page
- 10.1101/gad.9.16.1965 · DOI
- 1993, ADP-ribosylation of rho p21 inhibits lysophos-phatidic acid-induced protein tyrosine phosphorylation and phosphatidylinositol 3-kinase activation in cultured Swiss 3T3 cells., J. Biol. Chem., 268, 24535, 10.1016/S0021-9258(19)74497-4 · DOI
- 10.1126/science.7716521 · DOI
- 10.1016/0955-0674(93)90014-H · DOI
- 10.1016/S0092-8674(00)81375-6 · DOI · Paper page
- 1996, Identification of the bud emergence gene BEM4 and its interactions with Rho-type GTPases in Saccharomyces cerevisiae., Mol. Cell. Biol., 16, 4387, 10.1128/MCB.16.8.4387 · DOI
- 10.1038/367040a0 · DOI
- 1995, A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20., EMBO J., 14, 1970, 10.1002/j.1460-2075.1995.tb07189.x · DOI
- 10.1126/science.8424175 · DOI
- 1996, Rho-associated kinase, a novel serine/threonine kinase, as a putative target for the small GTP binding protein Rho., EMBO J., 15, 2208, 10.1002/j.1460-2075.1996.tb00574.x · DOI
- 10.1074/jbc.271.15.8971 · DOI
- 10.1038/375338a0 · DOI
- 10.1073/pnas.88.12.5167 · DOI
- 10.1016/S0092-8674(05)80019-4 · DOI
- 1994, Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines., Mol. Cell. Biol., 14, 3276
- 1995, Overexpression of PKC ζ in NIH 3T3 cells doses not induce cell transformation nor tumorigenicity and does not alter NF κB activity., Oncogene, 10, 2213
- 1996, Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4., J. Immunol., 156, 4146, 10.4049/jimmunol.156.11.4146 · DOI
- 10.1074/jbc.271.19.11209 · DOI
- 10.1126/science.8456305 · DOI · Paper page
- 10.1016/0092-8674(95)90005-5 · DOI
- 1995, Overexpression of RelA in transgenic mouse thymocytes: Specific increase in levels of the inhibitor protein IκBα, Mol. Cell. Biol., 15, 3523, 10.1128/MCB.15.7.3523 · DOI
- 1993, Tumorigenic activity of rho genes from Aplysia californica., Oncogene, 8, 1285
- 1995, Critical role of Rho in cell transformation by oncogenic Ras., Oncogene, 10, 2289
- 10.1038/374457a0 · DOI
- 10.1002/bies.950170507 · DOI
- 10.1016/0092-8674(95)90415-8 · DOI
- 10.1016/0092-8674(92)90553-O · DOI
- 10.1146/annurev.cb.10.110194.002201 · DOI
- 10.1016/0092-8674(94)90056-6 · DOI
- 10.1016/S0968-0004(00)89022-2 · DOI
- 10.1016/0092-8674(95)90506-5 · DOI
- 1994, A proteasome inhibitor prevents activation of NFκB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NFκB., EMBO J., 13, 5433, 10.1002/j.1460-2075.1994.tb06878.x · DOI
- 10.1101/gad.9.22.2723 · DOI
- 10.1126/science.271.5249.645 · DOI
- 10.1016/0092-8674(95)90416-6 · DOI
- 10.1016/0092-8674(95)90507-3 · DOI
- 1995, N- and C-terminal sequences control degradation of MAD3/IκBα in response to inducers of NF-κB activity., Mol. Cell. Biol., 15, 5339, 10.1128/MCB.15.10.5339 · DOI
- 1993, Activation of platelet phosphatidylinositide 3-kinase requires the small GTP-binding protein Rho., J. Biol. Chem., 268, 22251, 10.1016/S0021-9258(18)41518-9 · DOI
Cited by
RHO GTPASES: Biochemistry and Biology
Jaffe, A. B., & Hall, A. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.020604.150721 · Cited by 3,009
Finkel, T. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80147-6 · Cited by 1,170
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
Caron, E., & Hall, A. (1998) · Science · doi:10.1126/science.282.5394.1717 · Cited by 1,019
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Wang, J.-B., Erickson, J. W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K. F., Ambrosio, A. L. B., Dias, S. M. G., Dang, C. V., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.009 · Cited by 821
TNF receptor subtype signalling: Differences and cellular consequences
MacEwan, D. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00262-5 · Cited by 610
Rac1 GTPase: A “Rac” of All Trades
Bosco, E. E., Mulloy, J. C., & Zheng, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8552-x · Cited by 350
Rho signals to cell growth and apoptosis
Aznar, S., & Lacal, J. C. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00412-8 · Cited by 310
Self-citationGranule protein processing and regulated secretion in neutrophils
Sheshachalam, A., Srivastava, N., Mitchell, T., Lacy, P., & Eitzen, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00448 · Cited by 247
Distinct functions of Rho and Rac are required for convergent extension during Xenopus gastrulation
Tahinci, E., & Symes, K. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00206-9 · Cited by 162
Li, X., Bu, X., Lu, B., Avraham, H., Flavell, R. A., & Lim, B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1158-1171.2002 · Cited by 153
Transforming growth factor-β1 regulates macrophage migration via RhoA
Kim, J.-S., Kim, J.-G., Moon, M.-Y., Jeon, C.-Y., Won, H.-Y., Kim, H.-J., Jeon, Y.-J., Seo, J.-Y., Kim, J.-I., Kim, J., et al. (2006) · Blood · doi:10.1182/blood-2005-10-009191 · Cited by 134
Zhou, P., Li, Y., Li, B., Zhang, M., Liu, Y., Yao, Y., & Li, D. (2019) · Oncogene · doi:10.1038/s41388-019-0806-6 · Cited by 108
Pai, S.-Y., Kim, C., & Williams, D. A. (2010) · Disease Markers · doi:10.1155/2010/380291 · Cited by 85
Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders
Troeger, A., & Williams, D. A. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.07.002 · Cited by 73
Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine‐rich protein 61
Walsh, C. T., Radeff‐Huang, J., Matteo, R., Hsiao, A., Subramaniam, S., Stupack, D., & Brown, J. H. (2008) · The FASEB Journal · doi:10.1096/fj.08-113266 · Cited by 47
Rho GTPases in neurodegeneration diseases
DeGeer, J., & Lamarche-Vane, N. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.016 · Cited by 46
The Role of RhoH in TCR Signalling and Its Involvement in Diseases
Ahmad Mokhtar, A. M., Hashim, I. F., Mohd Zaini Makhtar, M., Salikin, N. H., & Amin-Nordin, S. (2021) · Cells · doi:10.3390/cells10040950 · Cited by 25
Koike, S., Yamasaki, K., Yamauchi, T., Shimada-Omori, R., Tsuchiyama, K., Ando, H., & Aiba, S. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.11.005 · Cited by 20
Metadata
- Authors
- Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., & Lacal, J. C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1997-02-15
- Volume
- 11
- Issue
- 4
- Pages
- 463-475
- ISSN
- 0890-9369
- 1549-5477
- Cited by
- 519
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review